Gene Cell Nano
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
News
- Save the Date for the Third Annual Meeting!
- Professor Arto Urtti secures two major U.S. research grants
- Professor Seppo Ylä-Herttuala receives the 2023 ESGCT Outstanding Achievement Award
- Professor Tetsuya Terasaki receives esteemed Ariëns award
- 15 million euros of EU funding granted for a joint project of European gene therapy research centers
Events
- The 3rd Annual GCN Meeting 18.-19.4.2024
- EV4US & FISEV Annual meeting: extracellular vesicle research days in Oulu 5.-6.2.2024
- AIX Forum: collaborative meeting between GeneCellNano and the FCAI Flagship
- Argumenta Healthy environment – healthy people workshop on extracellular vesicles 19.6.2023
- Research Seminar Afternoon of the CVD Research Community and the GeneCellNano Flagship 7.6.2023
GeneCellNano is an interdisciplinary community of top experts specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechniques linked with their management.